Reminder: Invitation to Roche's virtual event on key oncology data presented at ASCO 2020 Montag, 25. Mai 2020 - 15:01

We are pleased to invite investors and analysts to participate in our virtual event on Friday, 29 May 2020, highlighting Roche data accepted for presentation via the ASCO20 Virtual Scientific Program May 29-31, 2020.

17:00 – 18:15 CEST / 16:00 - 17:15 BST
11:00 – 12:15 am EDT / 8:00 - 9:15 am PDT

The event will start with a presentation, followed by a Q&A session (live access to the speakers).

Speakers:
Ira Mellman, Vice President, Cancer Immunology, Genentech Research and Early Development

Alan Sandler, M.D., Global Head of Product Development - Solid Tumors

Access to live event
Please pre-register for our webinar here.*

A replay of the webcast will be available via > ir.roche.com

*privacy notice

Best regards,

Karl Mahler
Head of Investor Relations and Roche Group Planning

Sabine Borngräber
Investor Relations Officer

Roche Investor Relations

Dr. Karl Mahler
Phone: +41 61 68-78503
e-mail: karl.mahler@roche.com

Jon Kaspar Bayard
Phone: +41 61 68-83894
e-mail: jon_kaspar.bayard@roche.com

Dr. Sabine Borngräber
Phone: +41 61 68-88027
e-mail: sabine.borngraeber@roche.com

Dr. Bruno Eschli
Phone: +41 61 68-75284
e-mail: bruno.eschli@roche.com

Dr. Birgit Masjost
Phone: +41 61 68-84814
e-mail: birgit.masjost@roche.com

Dr. Gerard Tobin
Phone: +41 61 68-72942
e-mail: gerard.tobin@roche.com

Investor Relations North America

Loren Kalm
Phone: +1 650 225 3217
e-mail: kalm.loren@gene.com

Dr. Lisa Tuomi
Phone: +1 650 467 8737
e-mail: tuomi.lisa@gene.com